Premenstrual water retention

Last updated

Premenstrual water retention (or premenstrual fluid retention) is the buildup of additional water or fluid in the body. This phenomenon can be seen in various forms like increasing weight gain and swollen belly, legs, or ankles. Water retention is a symptom felt by some people of all backgrounds before their menstruation onset and was listed as one of the most common premenstrual symptoms in addition to cramping and back pain. [1] There is a study that mentions the age effect being potentially linked to the intensity of symptoms, where the maximum symptom intensity was seen around age 35. [1] This symptom, among others, have been connected to premenstrual syndrome (PMS), which is experienced by people days before their menstrual cycle begins. [2] [3] However, water retention itself can cause symptoms similar to those of PMS like body aches, headaches, and nausea. The actual duration of how long symptoms can last varies in length, from a few days to two weeks. [3]

Contents

Premenstrual water retention could be passed off as little weight gain before the start of a menstruation cycle, but should be carefully watched if weight is gained quickly within days. Water retention can cause serious consequences in people who have a kidney or cardiovascular disease and should take extra caution when experiencing this symptom. [4] [5]

As of now, the actual cause of water retention remains unclear. It was noted that there is no correlation to serum levels of progesterone or estradiol according to actual data, [6] but it is thought to be caused by hormone changes during the menstrual cycle through high levels of circulating progesterone, estrogen, and prolactin, which stimulate secretory cells in the body. [7] [8] [9] It is also thought that diet may play a role in increased water retention, such as salt and magnesium consumption, and fluid intake. [10]

Although the cause is still unclear, there are ways to relieve or manage water retention and symptoms caused by it. These methods include both medication (like water pills) and non-medication (diet control) management.

Symptoms

Adolescents and adults have reported water retention symptoms days prior to their menstrual cycle. The symptoms can appear up to two weeks before the menstrual cycle (before the luteal phase) and can present as physical symptoms such as breast tenderness, weight gain, and bloating. [11] The Penn Daily Symptom Rating Form was used in multiple studies that demonstrated these symptoms as core symptoms of the premenstrual cycle. [12]

Causes

Water retention during the premenstrual cycle can be linked to the use of conventional oral contraceptives. This is due to them containing estrogen and progestin. [13] Synthetic progestin lacks the ability to antagonize mineralocorticoid receptors, leading to more sodium and water retention and subsequently, temporary weight gain. [14] In addition, estrogen is known to interfere with the renin-angiotensin-aldosterone system (RAAS), since high concentrations of estrogen causes the release of more angiotensin II and aldosterone. [14]

Treatment

Overview

There are pharmacological and non-pharmacological treatment options in alleviating symptoms and providing relief during the phase of premenstrual fluid retention. Currently, pharmacological agents that are often used to treat premenstrual water retention in removing or limiting the fluid that is present. [10] Non-pharmacological considerations to reduce the effects of the condition is focused on an individual's diet and activity levels such as exercise [10]

Pharmacological

Hormonal treatments

Hormonal treatments such as oral contraceptives or intrauterine devices (IUDS) alters the menstrual cycle and lessen the amount of fluid retention. [15] Within the four phases of the menstrual cycle, water retention occurs during the Luteal phase due to the production of the hormone progesterone and estrogen.[ unreliable source? ] [16] The increase of these hormones results in an increase in water retention. Hormonal treatments are then used to reduce the amount of progesterone and estrogen that are produces and therefore, leading to a reduce amount of fluid.[ citation needed ][ medical citation needed ]

Diuretics

In the setting of increased fluid retention, the use of Diuretics is for the removal of fluid in the body. Diuretics are known as one of the main therapies for volume overload and includes several classes whose mechanisms of actions, and pharmacokinetics are involved in the principles of nephrology. [17] The therapy consists of drugs that pharmacologically adjusts the renal fluid regulation in favor of excreting water and electrolytes. [18] This class of drugs works to achieves the objective of fluid removal through the increase in production and volume of urine. [18]

Midol

A popular pharmacologic over-the-counter treatment on the market to alleviate symptoms associated with menstrual cycles is Midol [ clarification needed ]. More specifically, many Midol products contain a mild diuretic in their active ingredients to help with bloating. [19] Pamabrom helps relief premenstrual and menstrual symptoms of water retention. It is a xanthine derivative that acts as a mild, short-acting diuretic that eliminates sodium and chloride and sometimes potassium. [19] Although the exact mechanism of how this works is still unclear, it is speculated to be due to increasing the GFR (glomerular filtration rate) and decreasing sodium reabsorption in the proximal tubule. [19] Some Midol products also contain caffeine as a diuretic. Caffeine increases the GFR by inhibiting adenosine receptors, thus preventing vasoconstriction of the afferent arteriole in the renal system. [20]

Inhibition of prostaglandins

Studies shows that minimizing of the use of the medication class non-steroidal anti inflammatory drugs (NSAIDs) such as Naproxen and Ibuprofen will reduce premenstrual fluid retention. NSAIDs mechanism of action consists of the inhibition of cyclooygenase (COX) which further inhibits the production of prostaglandins and resulting in the reduction of renal water and sodium excretion in the kidneys. [21]

Non-pharmacological

Magnesium supplements

There is ongoing research regarding the efficacy of magnesium supplement in improving premenstrual symptoms and effectively reducing water retention. They may increase fluid output which can reduce premenstrual fluid retention and alleviate symptoms.[ better source needed ] [10]

Exercise

In several studies, it was shown that people experiencing PMS symptoms had a decrease in water retention and breast tenderness when they exercised regularly compared to those who did not. [22] [23]

Diet

Studies have shown a positive correlation between PMS symptoms and foods that are high in calories, fat, salt, and sugar. [24] Instead, individuals should focus on incorporating more fruits and vegetables that are high in fiber and anti-oxidant properties to reduce PMS symptoms. [25] Consuming smaller meals or limiting the amount of food can help minimize the occurrence of symptoms since more food consumed causes more volume in the body. [26]

Society and culture

Traditional Chinese medicine

In Traditional Chinese Medicine, PMS is seen to be caused by the qi in the liver being blocked which leads to an accumulation of blood flow in the lower half of the body. Additionally, the spleen and the stomach have an impact on water retention due to their role in digestion and nutrient breakdown. To open up the qi, people can be treated with herbs, acupuncture, diet therapy, and deep breathing exercises. [27] PMS symptoms are also tied to changes in yin and yang that happen throughout the menstrual cycle. [28]

Acupuncture has been traditionally used as a Chinese medical treatment for over 2000 years in Asian countries to relieve PMS symptoms. It has been speculated to work by altering blood flow, inflammatory markers, and prostaglandin levels. Especially because inflammatory markers is the main pathway in decreasing premenstrual physical symptoms such as breast tenderness and water retention. [29] The acupoints that are most commonly used to relieve PMS symptoms due to hormone regulating properties and regulation of the nervous system include SP6, LR3, and RN4. [28]

Qigong is another practice that consists of meditation, breathing-exercises, dance-like movements, and relaxation that has been shown to reduce PMS symptoms when compared to placebo results. [30] Practitioners of qigong can redirect or emit their qi to heal themselves or others, helping to improve symptoms of negative feelings, water retention, etc. [30]

Drinking green tea, which is one of the most consumed beverages, is also encouraged to reduce water retention due to its diuretic properties. Green tea contains caffeine and catechins which are anti-oxidants.[ medical citation needed ] [31]

Middle Eastern countries

Many studies regarding the symptoms of PMS were based off populations in the Western or Far Eastern countries. However, the prevalence of PMS is just as dominant in Middle Eastern countries like Saudi Arabia and Palestine. These studies looked into many risk factors that could be correlated with symptom onsets but interestingly have shown that neither smoking or medical history (like chronic illnesses or medications) were related to an increase in symptoms. [32] [33] The frequency these symptoms were mainly associated with people who have family history of PMS symptoms [33] and dietary habits. [32] [33] These studies observed the effects certain types of drinks (caffeinated) may have on the severity and frequency of symptoms but noted that the amount of fluid intake was not taken into account. [32] [33]

See also

Related Research Articles

<span class="mw-page-title-main">Estrogen</span> Primary female sex hormone

Estrogen is a category of sex hormone responsible for the development and regulation of the female reproductive system and secondary sex characteristics. There are three major endogenous estrogens that have estrogenic hormonal activity: estrone (E1), estradiol (E2), and estriol (E3). Estradiol, an estrane, is the most potent and prevalent. Another estrogen called estetrol (E4) is produced only during pregnancy.

<span class="mw-page-title-main">Menstruation</span> Shedding of the uterine lining

Menstruation is the regular discharge of blood and mucosal tissue from the inner lining of the uterus through the vagina. The menstrual cycle is characterized by the rise and fall of hormones. Menstruation is triggered by falling progesterone levels and is a sign that pregnancy has not occurred.

<span class="mw-page-title-main">Progesterone</span> Sex hormone

Progesterone (P4) is an endogenous steroid and progestogen sex hormone involved in the menstrual cycle, pregnancy, and embryogenesis of humans and other species. It belongs to a group of steroid hormones called the progestogens and is the major progestogen in the body. Progesterone has a variety of important functions in the body. It is also a crucial metabolic intermediate in the production of other endogenous steroids, including the sex hormones and the corticosteroids, and plays an important role in brain function as a neurosteroid.

<span class="mw-page-title-main">Edema</span> Accumulation of excess fluid in body tissue

Edema, also spelled oedema, and also known as fluid retention, dropsy, hydropsy and swelling, is the build-up of fluid in the body's tissue. Most commonly, the legs or arms are affected. Symptoms may include skin which feels tight, the area may feel heavy, and joint stiffness. Other symptoms depend on the underlying cause.

<span class="mw-page-title-main">Menstrual cycle</span> Natural changes in the human female reproductive system

The menstrual cycle is a series of natural changes in hormone production and the structures of the uterus and ovaries of the female reproductive system that makes pregnancy possible. The ovarian cycle controls the production and release of eggs and the cyclic release of estrogen and progesterone. The uterine cycle governs the preparation and maintenance of the lining of the uterus (womb) to receive an embryo. These cycles are concurrent and coordinated, normally last between 21 and 35 days, with a median length of 28 days, and continue for about 30–45 years.

Premenstrual syndrome (PMS) is a disruptive set of emotional and physical symptoms that regularly occur in the one to two weeks before the start of each menstrual period. Symptoms resolve around the time menstrual bleeding begins. Different women experience different symptoms. Premenstrual syndrome commonly produces one or more physical, emotional, or behavioral symptoms, that resolve with menses. The range of symptoms is wide, and most commonly are breast tenderness, bloating, headache, mood swings, depression, anxiety, anger, and irritability. To be diagnosed as PMS, rather than a normal discomfort of the menstrual cycle, these symptoms must interfere with daily living, during two menstrual cycles of prospective recording. These symptoms are nonspecific and are seen in women without PMS. Often PMS-related symptoms are present for about six days. An individual's pattern of symptoms may change over time. PMS does not produce symptoms during pregnancy or following menopause.

<span class="mw-page-title-main">Progestogen (medication)</span> Medication producing effects similar to progesterone

A progestogen, also referred to as a progestagen, gestagen, or gestogen, is a type of medication which produces effects similar to those of the natural female sex hormone progesterone in the body. A progestin is a synthetic progestogen. Progestogens are used most commonly in hormonal birth control and menopausal hormone therapy. They can also be used in the treatment of gynecological conditions, to support fertility and pregnancy, to lower sex hormone levels for various purposes, and for other indications. Progestogens are used alone or in combination with estrogens. They are available in a wide variety of formulations and for use by many different routes of administration. Examples of progestogens include natural or bioidentical progesterone as well as progestins such as medroxyprogesterone acetate and norethisterone.

<span class="mw-page-title-main">Dysmenorrhea</span> Pain during and sometimes before menstruation

Dysmenorrhea, also known as period pain, painful periods or menstrual cramps, is pain during menstruation. Its usual onset occurs around the time that menstruation begins. Symptoms typically last less than three days. The pain is usually in the pelvis or lower abdomen. Other symptoms may include back pain, diarrhea or nausea.

Premenstrual dysphoric disorder (PMDD) is a mood disorder characterized by emotional, cognitive, and physical symptoms. PMDD causes significant distress or impairment in menstruating people during the luteal phase of the menstrual cycle. The symptoms occur in the luteal phase, improve within a few days after the onset of menses, and are minimal or absent in the week after menses. PMDD has a profound impact on a person's quality of life and dramatically increases the risk of suicidal ideation and even suicide attempts. Many women of reproductive age experience discomfort or mild mood changes prior to menstruation. However, 5–8% experience severe premenstrual syndrome causing significant distress or functional impairment. Within this population of reproductive age, some will meet the criteria for PMDD.

Breast pain is the symptom of discomfort in either one or both breasts. Pain in both breasts is often described as breast tenderness, is usually associated with the menstrual period and is not serious. Pain that involves only one part of a breast is more concerning, particularly if a hard mass or nipple discharge is also present.

<span class="mw-page-title-main">Drospirenone</span> Medication drug

Drospirenone is a progestin and antiandrogen medication which is used in birth control pills to prevent pregnancy and in menopausal hormone therapy, among other uses. It is available both alone under the brand name Slynd and in combination with an estrogen under the brand name Yasmin among others. The medication is an analog of the drug spironolactone. Drospirenone is taken by mouth.

<span class="mw-page-title-main">Luteal phase</span> The latter part of the menstrual cycle associated with ovulation and an increase in progesterone

The menstrual cycle is on average 28 days in length. It begins with menses during the follicular phase, followed by ovulation and ending with the luteal phase. Unlike the follicular phase which can vary in length among individuals, the luteal phase is typically fixed at approximately 14 days and is characterized by changes to hormone levels, such as an increase in progesterone and estrogen levels, decrease in gonadotropins such as follicle-stimulating hormone (FSH) and luteinizing hormone (LH), changes to the endometrial lining to promote implantation of the fertilized egg, and development of the corpus luteum. In the absence of fertilization by sperm, the corpus luteum atrophies leading to a decrease in progesterone and estrogen, an increase in FSH and LH, and shedding of the endometrial lining (menses) to begin the menstrual cycle again.

<span class="mw-page-title-main">Menstrual disorder</span> Medical condition affecting menstrual cycle

A menstrual disorder is characterized as any abnormal condition with regards to a woman's menstrual cycle. There are many different types of menstrual disorders that vary with signs and symptoms, including pain during menstruation, heavy bleeding, or absence of menstruation. Normal variations can occur in menstrual patterns but generally menstrual disorders can also include periods that come sooner than 21 days apart, more than 3 months apart, or last more than 10 days in duration. Variations of the menstrual cycle are mainly caused by the immaturity of the hypothalamic-pituitary-ovarian (HPO) axis, and early detection and management is required in order to minimize the possibility of complications regarding future reproductive ability.

Estrogen dominance (ED) is a theory about a metabolic state where the level of estrogen outweighs the level of progesterone in the body. This is said to be caused by a decrease in progesterone without a subsequent decrease in estrogen.

<span class="mw-page-title-main">Catamenial epilepsy</span> Epilepsy exacerbated during certain phases of the menstrual cycle

Catamenial epilepsy is a form of epilepsy in women where seizures are exacerbated during certain phases of the menstrual cycle. In rare cases, seizures occur only during certain parts of the cycle; in most cases, seizures occur more frequently during certain parts of the cycle. Catamenial epilepsy is underlain by hormonal fluctuations of the menstrual cycle where estrogens promote seizures and progesterone counteracts seizure activity.

<span class="mw-page-title-main">Progesterone (medication)</span> Medication and naturally occurring steroid hormone

Progesterone (P4) is a medication and naturally occurring steroid hormone. It is a progestogen and is used in combination with estrogens mainly in hormone therapy for menopausal symptoms and low sex hormone levels in women. It is also used in women to support pregnancy and fertility and to treat gynecological disorders. Progesterone can be taken by mouth, vaginally, and by injection into muscle or fat, among other routes. A progesterone vaginal ring and progesterone intrauterine device used for birth control also exist in some areas of the world.

<span class="mw-page-title-main">Seed cycling</span> Eating edible seeds to alter menstrual cycle


Seed cycling is the rotation of different edible seeds into the diet at different times in the menstrual cycle. Practitioners believe that since some seeds promote estrogen production, and others promote progesterone production, that eating these seeds in the correct parts of the menstrual cycle will balance the hormonal rhythm.

Menstrual suppression refers to the practice of using hormonal management to stop or reduce menstrual bleeding. In contrast to surgical options for this purpose, such as hysterectomy or endometrial ablation, hormonal methods to manipulate menstruation are reversible.

Sleep problems in women can manifest at various stages of their life cycle. Both subjective and objective data indicate that women are at an increased risk of experiencing different types of sleeping problems during different life stages. Factors such as hormonal changes, aging, psycho-social aspects, physical and psychological conditions, and the presence of sleeping disorders can disrupt women's sleep. Research supports the presence of disturbed sleep during the menstrual cycle, pregnancy, postpartum period, and menopausal transition. The relationship between sleep and women's psychological well-being suggests that the underlying causes of sleep disturbances are often multi-factorial throughout a woman's lifespan.

Menstruation can have a notable impact on mental health, with some individuals experiencing mood disturbances and psychopathological symptoms during their menstrual cycle. Menstruation involves hormonal fluctuations and physiological changes in the body, which can affect a person's mood and psychological state. Many individuals report experiencing mood swings, irritability, anxiety, and even depression in the days leading up to their menstrual period. This cluster of symptoms is often referred to as premenstrual syndrome (PMS). For some individuals, the psychopathological symptoms associated with menstruation can be severe and debilitating, leading to a condition known as premenstrual dysphoric disorder (PMDD). PMDD is characterized by intense mood disturbances, cognitive, and somatic symptoms, which occur in a cyclical pattern linked to the menstrual cycle. In addition to PMDD, menstruation can exacerbate existing mental health conditions. The complex relationship between menstruation and mental well-being has garnered increased attention in both scientific research and public discourse.

References

  1. 1 2 Dennerstein L, Lehert P, Heinemann K (June 2012). "Epidemiology of premenstrual symptoms and disorders". Menopause International. 18 (2): 48–51. doi:10.1258/mi.2012.012013. PMID   22611221. S2CID   12975168.
  2. ↑ [ better source needed ] "Premenstrual Syndrome (PMS)". www.hopkinsmedicine.org. 2019-11-19. Retrieved 2023-07-26.
  3. 1 2 Yonkers KA, O'Brien PM, Eriksson E (April 2008). "Premenstrual syndrome". Lancet. 371 (9619): 1200–1210. doi:10.1016/s0140-6736(08)60527-9. PMC   3118460 . PMID   18395582.
  4. ↑ [ better source needed ] "Fluid retention: What it can mean for your heart". Harvard Health. 2014-01-01. Retrieved 2023-07-31.
  5. ↑ "Chronic kidney disease". www.nhsinform.scot. Retrieved 2023-07-31.
  6. ↑ White CP, Hitchcock CL, Vigna YM, Prior JC (2011). "Fluid Retention over the Menstrual Cycle: 1-Year Data from the Prospective Ovulation Cohort". Obstetrics and Gynecology International. 2011: 138451. doi: 10.1155/2011/138451 . PMC   3154522 . PMID   21845193.
  7. ↑ Jadack RA (25 June 2014). "Female Genital and Reproductive Function". In Copstead-Kirkhorn LC, Banasik JL (eds.). Pathophysiology. Elsevier Health Sciences. pp. 660–. ISBN   978-0-323-29317-4.
  8. ↑ Farage MA, Neill S, MacLean AB (January 2009). "Physiological changes associated with the menstrual cycle: a review". Obstetrical & Gynecological Survey. 64 (1): 58–72. doi:10.1097/OGX.0b013e3181932a37. PMID   19099613. S2CID   22293838.
  9. ↑ Pooler C (1 October 2009). Porth Pathophysiology: Concepts of Altered Health States. Lippincott Williams & Wilkins. pp. 1075, 1107. ISBN   978-1-60547-781-7.
  10. 1 2 3 4 [ better source needed ] "Kick PMS bloat to the curb". Mayo Clinic. Retrieved 2023-07-31.
  11. ↑ Marjoribanks J, Brown J, O'Brien PM, Wyatt K, et al. (Cochrane Gynaecology and Fertility Group) (June 2013). "Selective serotonin reuptake inhibitors for premenstrual syndrome". The Cochrane Database of Systematic Reviews. 2013 (6): CD001396. doi:10.1002/14651858.CD001396.pub3. PMC   7073417 . PMID   23744611.
  12. ↑ Freeman EW, Halberstadt SM, Rickels K, Legler JM, Lin H, Sammel MD (January 2011). "Core symptoms that discriminate premenstrual syndrome". Journal of Women's Health. 20 (1): 29–35. doi:10.1089/jwh.2010.2161. PMC   3017419 . PMID   21128818.
  13. ↑ Pérez-López FR (June 2008). "Clinical experiences with drospirenone: from reproductive to postmenopausal years". Maturitas. 60 (2): 78–91. doi:10.1016/j.maturitas.2008.03.009. PMID   18468818.
  14. 1 2 Oelkers WH (October 2005). "Drospirenone in combination with estrogens: for contraception and hormone replacement therapy". Climacteric. 8 (Suppl 3): 19–27. doi:10.1080/13697130500330341. PMID   16203652. S2CID   42837148.
  15. ↑ "What are the treatment options for heavy periods?", InformedHealth.org [Internet], Institute for Quality and Efficiency in Health Care (IQWiG), 2017-05-04, retrieved 2023-07-26
  16. ↑ [ unreliable source? ]Gunasekara O (2020-05-05). "Bioidentical Hormones and Bloating - How They Can Help". BodyLogicMD. Retrieved 2023-07-26.
  17. ↑ Novak JE, Ellison DH (August 2022). "Diuretics in States of Volume Overload: Core Curriculum 2022". American Journal of Kidney Diseases. 80 (2): 264–276. doi: 10.1053/j.ajkd.2021.09.029 . PMID   35190215. S2CID   247002373.
  18. 1 2 Arumugham VB, Shahin MH (2023). "Therapeutic Uses of Diuretic Agents". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID   32491770 . Retrieved 2023-07-26.
  19. 1 2 3 Di Girolamo G, Sánchez AJ, De Los Santos AR, González CD (March 2004). "Is acetaminophen, and its combination with pamabrom, an effective therapeutic option in primary dysmenorrhoea?". Expert Opinion on Pharmacotherapy. 5 (3): 561–570. doi:10.1517/14656566.5.3.561. PMID   15013925. S2CID   26876035.
  20. ↑ Marx B, Scuvée É, Scuvée-Moreau J, Seutin V, Jouret F (May 2016). "[Mechanisms of caffeine-induced diuresis]". Médecine/Sciences. 32 (5): 485–490. doi: 10.1051/medsci/20163205015 . PMID   27225921.
  21. ↑ Lauridsen TG, Vase H, Starklint J, Graffe CC, Bech JN, Nielsen S, Pedersen EB (October 2010). "Increased renal sodium absorption by inhibition of prostaglandin synthesis during fasting in healthy man. A possible role of the epithelial sodium channels". BMC Nephrology. 11: 28. doi: 10.1186/1471-2369-11-28 . PMC   2988774 . PMID   21029429.
  22. ↑ Prior JC, Vigna Y, Sciarretta D, Alojado N, Schulzer M (March 1987). "Conditioning exercise decreases premenstrual symptoms: a prospective, controlled 6-month trial". Fertility and Sterility. 47 (3): 402–408. doi: 10.1016/S0015-0282(16)59045-1 . PMID   3549364.
  23. ↑ Stoddard JL, Dent CW, Shames L, Bernstein L (January 2007). "Exercise training effects on premenstrual distress and ovarian steroid hormones". European Journal of Applied Physiology. 99 (1): 27–37. doi:10.1007/s00421-006-0313-7. PMID   17039366. S2CID   1605727.
  24. ↑ Vani KR, Kumar VR (November 2013). "Menstrual abnormalities in school going girls - are they related to dietary and exercise pattern?". Journal of Clinical and Diagnostic Research. 7 (11): 2537–2540. doi:10.7860/JCDR/2013/6464.3603. PMC   3879880 . PMID   24392394.
  25. ↑ Liu RH (September 2003). "Health benefits of fruit and vegetables are from additive and synergistic combinations of phytochemicals". The American Journal of Clinical Nutrition. 78 (3 Suppl): 517S–520S. doi: 10.1093/ajcn/78.3.517S . PMID   12936943.
  26. ↑ Sullivan SN (July 1994). "Functional abdominal bloating". Journal of Clinical Gastroenterology. 19 (1): 23–27. doi:10.1097/00004836-199407000-00007. PMID   7930428.
  27. ↑ Chou PB, Morse CA (April 2005). "Understanding premenstrual syndrome from a Chinese medicine perspective". Journal of Alternative and Complementary Medicine. 11 (2): 355–361. doi:10.1089/acm.2005.11.355. PMID   15865504.
  28. 1 2 Zhang J, Cao L, Wang Y, Jin Y, Xiao X, Zhang Q (2019-06-25). "Acupuncture for Premenstrual Syndrome at Different Intervention Time: A Systemic Review and Meta-Analysis". Evidence-Based Complementary and Alternative Medicine. 2019: 6246285. doi: 10.1155/2019/6246285 . PMC   6614973 . PMID   31341497.
  29. ↑ Armour M, Ee CC, Hao J, Wilson TM, Yao SS, Smith CA, et al. (Cochrane Gynaecology and Fertility Group) (August 2018). "Acupuncture and acupressure for premenstrual syndrome". The Cochrane Database of Systematic Reviews. 2018 (8): CD005290. doi:10.1002/14651858.CD005290.pub2. PMC   6513602 . PMID   30105749.
  30. 1 2 Jing Z, Yang X, Ismail KM, Chen X, Wu T, et al. (Cochrane Gynaecology and Fertility Group) (January 2009). "Chinese herbal medicine for premenstrual syndrome". The Cochrane Database of Systematic Reviews (1): CD006414. doi:10.1002/14651858.CD006414.pub2. PMID   19160284.
  31. ↑ [ non-primary source needed ]Chakraborty M, Kamath JV, Bhattacharjee A (2014-11-06). "Potential Interaction of Green Tea Extract with Hydrochlorothiazide on Diuretic Activity in Rats". International Scholarly Research Notices. 2014: 273908. doi: 10.1155/2014/273908 . PMC   4897558 . PMID   27355016.
  32. 1 2 3 Abu Alwafa R, Badrasawi M, Haj Hamad R (June 2021). "Prevalence of premenstrual syndrome and its association with psychosocial and lifestyle variables: a cross-sectional study from Palestine". BMC Women's Health. 21 (1): 233. doi: 10.1186/s12905-021-01374-6 . PMC   8178841 . PMID   34090416.
  33. 1 2 3 4 Rasheed P, Al-Sowielem LS (November 2003). "Prevalence and predictors of premenstrual syndrome among college-aged women in Saudi Arabia". Annals of Saudi Medicine. 23 (6): 381–387. doi: 10.5144/0256-4947.2003.381 . PMID   16868373.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.